Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
A Study of Tulisokibart for Adults with Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)
GermanyA Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin
BelgiumA Study of MAS825 in Children and Adults with Still's Disease to Test How Well It Works and How Safe It Is
FranceStudy of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration
SwedenA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
AustriaA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
BulgariaStudy of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
BelgiumStudy of IMVT-1402 Treatment for Adults with Graves' Disease
BulgariaStudy of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments
BelgiumStudy of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)
GreeceStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
BelgiumStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
CzechiaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
